card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services

Learn more
English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search
hero bg-3275_Young scientist works in modern laboratory

DISCOVERY SCIENCES

Antibody discovery campaigns

Home / Services / Discovery Sciences

At Specifica our goal is to generate as many different target-specific antibodies as possible that meet your unique requirements. We have generated more than 100 naïve individual libraries using different scaffolds, formats, variable gene sources and diversity sets.

Using three powerful coordinating technologies

specifica-approach-1

 

We first carry out selections from our Generation 3 phage display libraries to obtain an initial pool of antibody leads with maximum diversity.

specifica-approach-2

 

Then, we use yeast display to narrow this down to a diverse, high affinity fully binding population, reflecting requirements for cross-reactivity, ligand antagonism or additional specificity needs.

specifica-approach-3

 

Finally, we evaluate selection outputs with next generation sequencing and AbXtract, Specifica’s next-generation sequencing (NGS) analysis software.

Antibody clustering

The sequences obtained by NGS are analyzed by machine learning to group antibodies into different clusters expected to bind the same epitope. Our selected antibodies have high affinities, inherently developable biophysical properties and broad diversity, making your transition from lead to drug that much faster.

 

The final product can be a panel of antibodies in any format, or an extensive list of different antibody clonotype sequences you can make and test in house.

 

Learn what we’re focusing on in the coming months:

Learn more about our proven process to deliver world-class antibody libraries and discovery campaigns: Antibody Libraries - Specifica Inc

Related services

card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate

Discovery Sciences

Learn more
card-3259_man in laboratory with tablet for medical analysis

Protein Sciences

Learn more
card-3234_Liquid drop from pipette to test tube

Antibody Libraries

Learn more
card-3229_test tubes for testing

In Vitro Immunology

Learn more
card-3276_A medical scientist is preparing a pathological specimen for diagnosis

Discovery Science Specialty Testing Services

Learn more
card-3259_man in laboratory with tablet for medical analysis

Additional Specialty Testing Services

Learn more
Learn more